| The Therapeutics Initiative's objectives are unbiased review and dissemination of therapeutic evidence. Our recommendations are intended to apply to most patients; exceptional patients require exceptional approaches. We are committed to evaluate the effectiveness of our educational activities using the Pharmacare/PharmaNet databases without identifying individual physicians, pharmacies or patients. The Therapeutics Initiative is funded through a 5-year grant to the University of British Columbia from the Government of British Columbia, Ministry of Health and Ministry Responsible for Seniors. |

Herbal Medicines
An Evidence Based Look
The medical use of herbs is widespread. In a multi-ethnic group of patients attending an emergency department in New York 22% reported that they used herbal medicines; use was highest among Asians, 37%.(1) It is important therefore for clinicians to document use of herbal medicines as part of the patients drug profile. Plants synthesize complex (organic) molecules for their structure and function, and therefore are a rich source of chemicals. Active chemicals purified from plants are accepted effective medications e.g. digoxin, and morphine. When parts of plants or crude extracts of plants are used for medicinal purposes they are called herbal medicines.
What is the active ingredient?
Most herbal medicines contain hundreds of chemicals and there is often no agreement as to which are potentially active. An example is garlic, comprised of many sulfur compounds, several of which are candidates for possible therapeutic activity.(2)
How can one be sure that herbal medicines contain wht is on the label?
The only regulatory requirements in Canada are that all products intended for medicinal use, including natural health products, are issued a Drug Identification Number. These numbers are not required for raw materials such as bulk herbs. Herbal medicines are not required to pass any regulatory analysis to be sold as a health food supplement. There are many examples of herbal medicines that have been adulterated with other (more toxic) herbs, potent drugs (e.g. phenylbutazone(3), synthetic corticosteroids and other prescription drugs), or heavy metals.(4)
How are herbal medicines standardized?
The chemical constituents of plants vary depending on the species, variety and part of the plant, with conditions of growth (soil, water and temperature), and with the age of the plant. These complexities and variations of chemical content make standardization essential. In some cases standardization is attempted, but it is difficult and seldom accomplished.
To establish the effectiveness of herbs as medicines, they must be tested in prospective, double blind, randomized, placebo-controlled clinical trials (RCTs). Relatively few herbs have been tested in this manner.
There is a general conception that, because herbs are "natural", they are completely safe. This is not true. Herbs and herbal preparations can cause toxic adverse effects(4,5,6,7), serious allergic reactions(8) and adverse drug interactions(6,9), and can interfere with laboratory tests.(10)
The Table provides an alphabetical list of some common herbal medicines with their traditional indications, present RCT evidence of effectiveness, and some known adverse effects. At the present time none of the RCT evidence of effectiveness can be considered conclusive; trials where some benefit over placebo has been shown require confirmation with larger trials of longer duration. There is very little data available for long term safety.
Summary
Plants are rich sources of chemicals and potential sources of effective medicines. However, more research, regulation, and standardization are required before herbal medicines can be recommended as effective and safe therapies.
| This Therapeutics Letter contains an assessment and synthesis of published (and whenever possible peer-reviewed) publications up to August 1,1998. We attempt to maintain the accuracy of the information contained in the Therapeutics Letter by extensive literature searches and verification by both the authors and the editorial board. In addition this Therapeutics Letter was submitted for review to 55 experts and primary care physicians in order to correct any identified shortcomings or inaccuracies and to ensure that the information is concise and relevant to clinicians. |
References: click here for a list of 87 references on this topic.
Table: Herbal Medicines - A brief summary of present evidence
| Common Name Botanical Name |
Traditional use |
RCT |
Result |
Adverse |
Ref. |
|---|---|---|---|---|---|
| Chamomile,
German Chamomilla recutita |
Tonic | 0 |
Allergy |
8, 11 | |
| Mouthwash, oral mucositis | 1 |
= |
|||
| Devils Claw Harpagophytum procumbens |
Antirheumatic (Low back pain) |
1 |
= |
12 | |
| Echinacea Echinacea purpurea |
Immune stimulant (upper respiratory infections) |
2 |
? |
Allergy |
8, 13,14 |
| Evening Primrose Oenothera biennis |
Atopic Dermatitis | 5 |
2 î , 3 = |
15-19 | |
| Rheumatoid arthritis | 3 |
? |
20-22 | ||
| Psoriatic arthritis | 1 |
= |
23 | ||
| Premenstrual syndrome | 2 |
= |
24,25 | ||
| Menopausal Flushing | 1 |
= |
26 | ||
| Obesity | 1 |
= |
27 | ||
| Ulcerative colitis | 1 |
= |
28 | ||
| Hyperactivity | 2 |
= |
29,30 | ||
| Raynaud's syndrome | 1 |
= |
31 | ||
| Sjögren's syndrome | 1 |
= |
32 | ||
| Psoriasis | 2 |
= |
23,33 | ||
| Feverfew Tanacetum parthenium |
Migraine | 2 |
î |
Allergy |
34,35 |
| Rheumatoid Arthritis | 1 |
= |
36 | ||
| Garlic Allium sativum |
BP Lowering | 7 |
? |
37 | |
| Cholesterol lowering | 17 |
? |
38-40 | ||
| Ginger Zingiber officinale |
Seasickness | 1 |
= |
41 | |
| Hyperemesis gravidarum | 1 |
î |
42 | ||
| Post op N/V | 3 |
2 î , 1 = |
43-45 | ||
| EGb 761 Ginkgo biloba |
Dementia progression | 5 |
î |
Bleeding |
9, 46-50 |
| Tinnitus | 2 |
1 î , 1 = |
51 | ||
| American Ginseng Panax quinquefolius |
Exercise performance | 1 |
= |
54 | |
| Korean
Ginseng (G115®) Panax ginseng |
Exercise performance | 2 |
= |
52, 53 | |
| Psychomotor performance | 1 |
= |
57 | ||
| Flu Vaccine Immun. Resp. | 1 |
î |
56 | ||
| Siberian Ginseng Eleutherococcus senticossus |
Exercise performance | 1 |
= |
41 | |
| Saint John's
Wort Hypericum perforatum |
Antidepressant | 2 |
î |
Skin photo-sensitivity |
58, 59 |
| Saw Palmetto (Pemixon®) Serenoa repens |
Prostatic hyperplasia | 2 |
î |
60, 61 | |
| Zemaphyte® Ten Herbs |
Atopic eczema | 1 |
î |
Liver Toxicity |
62, 63 |
î - benefit as compared to placebo.
? - reported benefit unlikely (due to design or analytical flaw).
= - same as compared to placebo
Please send feedback!
Back to Therapeutics Letter.
Back to the Therapeutics
Initiative Home Page.
©Therapeutics Initiative. Last updated: August 31, 1998.